-

Blackstone Announces Appointment of Jeff Margolis, Leading Healthcare Information Technology Executive, as Senior Advisor

NEW YORK--(BUSINESS WIRE)--Blackstone (NYSE:BX) today announced the appointment of Jeff Margolis, former Chairman and CEO of TriZetto and the prior CEO and current Chairman of Welltok, Inc., as a Senior Advisor. Mr. Margolis brings more than 35 years of knowledge and experience growing innovative healthcare technology and service organizations, from early-stage through category-leadership, to advise Blackstone and its portfolio companies.

Ram Jagannath, a Senior Managing Director at Blackstone, said: “We’re thrilled to have Jeff join us as a Senior Advisor as we continue to identify and back innovators in the healthcare space. His strategic expertise in applying advanced technologies to address the complex challenges across the healthcare ecosystem will help our team better invest in, and support, the evolution and expansion of leading businesses in this industry.”

Jeff Margolis added: “I’m excited to support the Blackstone team’s commitment to systematically apply capital and industry thought leadership to accelerate progress at the nexus of healthcare and technology. Blackstone’s expertise and operational resources can play a crucial role in scaling the next generation of healthcare technology and services companies that meaningfully improve the health of individuals and populations across the globe.”

Jon Korngold, Global Head of Blackstone Growth, said: “We’re excited to welcome Jeff as a Senior Advisor. His long-standing, multi-faceted experience in healthcare information technology across private and government payers, providers, employers and pharma will benefit both our investment professionals and our portfolio companies as we help entrepreneurs navigate rapidly changing environments.”

Mr. Margolis’ extensive experience includes a decade as a Chief Information and Technology Officer, followed by 20 years as the CEO and/or Chairman of publicly traded and private healthcare technology companies. He most recently served as the Chairman and CEO at Welltok, Inc., where, over seven years, he led the company from a pre-revenue start-up to become a leading enterprise consumer activation company, which engaged with consumers 193 million times in 2020. Before joining Welltok, Inc., Mr. Margolis founded and spent 14 years at TriZetto Corporation, the first vertical SaaS enterprise software company, where he served as chairman and CEO. He is the author of several books, including his soon-to-be-released Not Just In Sickness, But Also In Health (ForbesBooks 2021).

Additionally, Mr. Margolis currently serves as Chairman at NextGen Healthcare (NASDAQ:NXGN), Vice Chairman at TriNetX and also as a board member at Alignment Healthcare. In the not-for-profit world, he serves as a board member of Hoag Hospital and is Chairman of Hoag Clinic, and is also Chairman of the University of California at Irvine's Center for Digital Transformation. Jeff is an AIPCA Certified Global Management Accountant and a Leadership Fellow with the National Association of Corporate Directors (NACD). Jeff holds a Bachelor of Science degree with high honors in Business Administration–Management Information Systems from the University of Illinois at Urbana-Champaign.

About Blackstone
Blackstone is one of the world’s leading investment firms. We seek to create positive economic impact and long-term value for our investors, the companies we invest in, and the communities in which we work. We do this by using extraordinary people and flexible capital to help companies solve problems. Our asset management businesses, with $584 billion in assets under management, include investment vehicles focused on private equity, real estate, public debt and equity, growth equity, opportunistic, non-investment grade credit, real assets and secondary funds, all on a global basis. Further information is available at www.blackstone.com. Follow Blackstone on Twitter @Blackstone.

Contacts

Matt Anderson
212-390-2472
matthew.anderson@blackstone.com

Blackstone

NYSE:BX

Release Versions

Contacts

Matt Anderson
212-390-2472
matthew.anderson@blackstone.com

More News From Blackstone

Blackstone Real Estate to Acquire 6M SF Industrial Portfolio Developed by Crow Holdings for $718M

NEW YORK & DALLAS--(BUSINESS WIRE)--Blackstone (NYSE: BX) and Crow Holdings, a leading real estate investment and development firm, today announced that Core+ funds affiliated with Blackstone Real Estate have agreed to acquire a 95 percent stake in an industrial portfolio developed by Crow Holdings for $718 million. Crow Holdings and its partners will retain 5 percent ownership. The portfolio consists of 25 Class A buildings totaling 6 million square feet and is predominantly located in high-ba...

Blackstone Life Sciences and Anthos Therapeutics Announce Novartis has Completed the Acquisition of Anthos Therapeutics in a Deal Valued at up to $3.1B, with $925M Paid Upfront

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Blackstone Life Sciences and Anthos Therapeutics, Inc., a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of cardiometabolic diseases, announced today that Novartis has completed its acquisition of Anthos Therapeutics in a transaction valued at up to $3.1 billion. Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture,...

Blackstone Announces SEC Effectiveness for Private Multi-Asset Credit and Income Fund (BMACX)

NEW YORK--(BUSINESS WIRE)--Blackstone (NYSE: BX) announced today that the Blackstone Private Multi-Asset Credit and Income Fund (BMACX) has been declared effective by the U.S. Securities and Exchange Commission. This marks a significant milestone for BMACX, which will aim to provide individual investors a one-stop, private multi-asset credit solution designed to access strategies across Blackstone’s $453 billion credit platform through an interval fund structure. BMACX will invest across privat...
Back to Newsroom